...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Discovery of a selective Na_V1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models
【24h】

Discovery of a selective Na_V1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models

机译:Discovery of a selective Na_V1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models

获取原文
获取原文并翻译 | 示例
           

摘要

Loss-of-function mutations in the human voltage-gated sodium channel Na_V1.7 result in a congenital indifference to pain. Selective inhibitors of Na_V1.7 are therefore likely to be powerful analgesics for treating a broad range of pain conditions. Herein we describe the identification of μ-SLPTX-Ssm6a, a unique 46-residue peptide from centipede venom that potently inhibits Na_V1.7 with an IC_(50) of ~25 nM. μ-SLPTX-Ssm6a has more than 150-fold selectivity for Na _V1.7 over all other human Na_V subtypes, with the exception of Na_V1.2, for which the selectivity is 32-fold. μ-SLPTX-Ssm6a contains three disulfide bonds with a unique connectivity pattern, and it has no significant sequence homology with any previously characterized peptide or protein. μ-SLPTX-Ssm6a proved to be a more potent analgesic than morphine in a rodent model of chemicalinduced pain, and it was equipotent with morphine in rodent models of thermal and acid-induced pain. This study establishes μ-SPTX-Ssm6a as a promising lead molecule for the development of novel analgesics targeting Na_V1.7, which might be suitable for treating a wide range of human pain pathologies.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号